problems with glp 1 drugs Can one drug do it all? Reviewing the expanding clinical universe of GLP-1 agonists Part 2 of a 3-Part

Others find that previously enjoyable foods become unappealing

Because they have not been tested, these GLP-1 patches may contain dangerous ingredients that could cause both mild and serious side effects

Reducing the risk of major cardiovascular events like heart attack, stroke, or death in adults with type 2 diabetes and known heart disease

Figure 3 shows the distribution of the total number of subjects in the studies included in this review

This could mean more people take the drug

Note that negative BMI change numbers represent BMI loss, and therefore a negative correlation implies increased drug efficacy with increased nausea